Eudaimonia Partners, LLC Baxter International Inc Transaction History

Eudaimonia Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$63.83 - $80.0 $4,787 - $6,000	-75 Reduced 1.71%	4,304 $276,000
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $87,224 - $101,525	-1,135 Reduced 20.58%	4,379 $340,000
Q3 2021 Oct 25, 2021	BUY	$73.77 - $83.61 $93,687 - $106,184	1,270 Added 29.92%	5,514 $443,000
Q2 2021 Aug 13, 2021	BUY	$80.5 - $88.01 $21,493 - $23,498	267 Added 6.71%	4,244 $342,000
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $834,680 - $940,135	-10,928 Reduced 73.32%	3,977 $335,000
Q4 2020 Feb 18, 2021	BUY	$75.39 - $82.36 $36,488 - $39,862	484 Added 3.36%	14,905 $1.2 Million
Q3 2020 Nov 23, 2020	BUY	$78.33 - $90.73 $1.13 Million - $1.31 Million	14,421 New	14,421 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$78.33 - $90.73 $306,035 - $354,482	-3,907 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$71.57 - $93.3 $20,683 - $26,963	289 Added 7.99%	3,907 $317,000
Q4 2019 May 05, 2020	BUY	$76.7 - $88.45 $277,500 - $320,012	3,618 New	3,618 $303,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.